智通财经APP获悉，最近几周，美国总统特朗普在"摇摆州"的赌场向汽车工人及支持者兜售其民粹主义 经济纲领。如今，他将目标转向了另一批受众——齐聚瑞士滑雪胜地达沃斯的全球精英群体。 特朗普已承诺，将在周三的世界经济论坛演讲中，详细公布一项覆盖面广泛的民生减负方案。华尔街各 大银行、科技企业以及房地产开发商，都被划入了这份方案的整治范围。 而就在他作出这一承诺之前的周末，特朗普放出的一系列强硬言论已让欧洲方面绷紧了神经。他高调宣 称要争取对格陵兰岛的控制权，还威胁要对一众支持格陵兰岛与丹麦维持隶属关系的北约盟友加征关 税。 周一，在欧洲国家计划举行单独会议以回应特朗普、且丹麦官员集体缺席本届达沃斯论坛之际，这位总 统似乎正试图通过发布关于抵押贷款利率及其经济议程的社交媒体贴文，将公众注意力重新拉回到"民 生减负"的议题上。 就在去年年底，特朗普还曾嘲讽"民生减负"是民主党的"骗局"。但随着共和党在去年11月的多场关键选 举中失利，民调又显示选民对其经济治理能力愈发不满，特朗普如今转而试图在这一议题上拿出实际行 动。 该经济议程的部分内容已逐渐浮出水面。白宫国家经济委员会主任凯文・哈西特透露，特朗普将推出一 项新规 ...

Core Viewpoint - President Trump's unexpected request for credit card companies to set a cap on interest rates at 10% could significantly impact the profitability of the financial sector, leading to a decline in financial stocks and raising concerns among bank executives during earnings calls [1][4]. Financial Sector Impact - The proposed interest rate cap is half of the current average rate on outstanding balances, potentially erasing billions in profits for credit card issuers [1]. - Major banks such as Capital One (COF.US), JPMorgan Chase (JPM.US), and American Express (AXP.US) experienced significant stock declines following the announcement [1]. - Analysts from KBW indicated that if the policy is implemented, it would severely weaken the profitability of credit card issuers and could trigger economic repercussions [4]. Legislative Developments - Trump has called for Congressional support for the Credit Card Competition Act, which targets the nearly $200 billion in swipe fees charged by banks and payment companies, negatively affecting stocks of Visa (V.US) and Mastercard (MA.US) [4]. - Some analysts doubt the feasibility of the interest rate cap, suggesting that the probability of it being enacted is less than 20% due to the lack of legislative support [4]. Broader Economic Effects - Bank executives have warned that the interest rate cap could lead to a significant economic slowdown and push consumers towards unregulated lending sources [5]. - The proposed changes are expected to have ripple effects beyond the financial sector, impacting industries such as airlines and retail, which rely on partnerships with credit card companies for substantial revenue [7]. - Airlines like Delta (DAL.US) and United Airlines (UAL.US) saw stock declines, as did retailers like Macy's (M.US) and Kohl's (KSS.US), due to concerns over the potential impact of the proposed legislation [7].

Market Overview - US stock index futures are all down, with Dow futures down 0.14%, S&P 500 futures down 0.15%, and Nasdaq futures down 0.27% [1] - European indices also show declines, with Germany's DAX down 0.10%, UK's FTSE 100 down 0.05%, France's CAC40 down 0.54%, and the Euro Stoxx 50 down 0.07% [2][3] Oil Market - WTI crude oil increased by 2.14%, reaching $60.59 per barrel, while Brent crude oil rose by 1.72%, reaching $64.97 per barrel [3][4] Inflation and Economic Indicators - The US December CPI is expected to rebound to 2.7% year-on-year, with a month-on-month increase of 0.3%. Core CPI is also projected to rise by 2.7% year-on-year and 0.3% month-on-month [4] - The anticipated rise in inflation is attributed to the reversal of factors that had previously suppressed inflation due to the government shutdown in November [4] Central Bank Developments - Global central banks are preparing a joint statement to support the independence of the Federal Reserve amid increasing political pressure from the Trump administration [5] - Concerns are growing that political pressures could undermine the Fed's focus on inflation and economic growth [5] Corporate News - Nvidia clarified that it does not require customers to make prepayments for purchasing H200 chips, countering reports of strict terms for Chinese customers [9] - JPMorgan reported a fourth-quarter non-GAAP EPS of $5.23, exceeding expectations, with revenue of $46.77 billion, a 6.9% year-on-year increase [9] - Delta Airlines reported a fourth-quarter non-GAAP EPS of $1.55, meeting expectations, but the stock fell 5% in pre-market trading [10] - Eli Lilly's weight loss drug Orforglipron is expected to be approved soon, with the company prepared to meet market demand [10] - Merck is looking to make significant acquisitions in the innovative drug sector, with plans to spend heavily before the expiration of its "K drug" patent [11] - AbbVie has committed to investing $100 billion in the US over the next decade in exchange for tariff exemptions [12]